NCT07530666 is a Phase 1, PHASE2 clinical trial of DS010 injection in Cancer, sponsored by Dartsbio Pharmaceuticals Ltd..

Who is sponsoring NCT07530666?

NCT07530666 is sponsored by Dartsbio Pharmaceuticals Ltd..

What drugs are being tested in NCT07530666?

Interventions in NCT07530666: DS010 injection, DS010 injection, DS010 injection, DS010 injection, DS010 injection, DS010 injection, DS010 injection, DS010 injection, DS010 injection, DS010 injection.

What condition does NCT07530666 study?

NCT07530666 studies Cancer, Cachexia.

Is NCT07530666 still recruiting?

NCT07530666 is currently not yet recruiting. Last updated 15 April 2026.

Last reviewed 2026-04-15 · How we verify

NCT07530666

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

Not yet recruiting Phase 1, PHASE2 Last updated 15 April 2026

What this trial tests

Phase 1, PHASE2 trial testing DS010 injection in Cancer in 58 participants. Not yet recruiting.

Timeline

30 April 2026

Primary endpoint
30 October 2027

30 April 2028

Quick facts

Lead sponsor	Dartsbio Pharmaceuticals Ltd.
Phase	Phase 1, PHASE2
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	58
Start date	30 April 2026
Primary completion	30 October 2027
Estimated completion	30 April 2028
Sites	1 location across China

Drugs / interventions tested

DS010 injection
DS010 injection
DS010 injection
DS010 injection
DS010 injection
DS010 injection
DS010 injection
DS010 injection
DS010 injection
DS010 injection

Conditions studied

Cancer — all drugs for Cancer →
Cachexia — all drugs for Cachexia →

Sponsor

Dartsbio Pharmaceuticals Ltd.

Who can join

18 and older, any sex, with Cancer or Cachexia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study to evaluate the safety, tolerability, and preliminary efficacy of DS010 in patients with cancer and cachexia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07530666 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dartsbio Pharmaceuticals Ltd.
Last refreshed: 15 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07530666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing